Xbrane Biopharma AB · OMXSTO:XBRANE

Xbrane Biopharma AB — Investor Presentation (March 2024)

28 slides from Xbrane Biopharma AB's investor presentation, March 2024

Slide 1: Xbrane Biopharma
RANE BIOPHARMA STO: XBRANE imilar Devel
Slide 2: Disclaimer
123456786ÿ84527648 4ÿ2 6ÿ57ÿ6ÿ448ÿ45ÿ4868 8ÿÿ448ÿ733ÿ64ÿ6ÿ4286ÿ78ÿ6ÿ84527648ÿ354ÿ8ÿ6ÿ35867648ÿÿ578437527ÿÿ3ÿ!"#$ÿ%&'()*+,-ÿ'.ÿ*+,ÿ)$./'+ÿ'+ÿ 0$#*12ÿ'2ÿ"#$ÿ&'()*+,ÿ*+3ÿ*+,ÿ'"#$.ÿ(*"$.4*1ÿ34/".405"$3ÿ'.ÿ/"*"$($+"/ÿ(*3$ÿ4+ÿ6'++$6"4'+ÿ74"#ÿ/56#ÿ).$/$+"*"4'+ÿ!"#$ÿ%8+2'.(76'+-9ÿ*+3ÿ,'5ÿ*.$ÿ"#$.$2'.$ÿ*3:4/
Slide 3: ^%T_ÿ*'V%ÿ&)* `249ÿ3 #5ÿ ÿ e6345ÿ5f7 49ÿ346ÿ 3 54 7ÿ346ÿ7 5 ÿ 45"ÿ25 43 gf346ÿhÿ7
012345366257757ÿ9 13ÿ53 ÿ354957ÿ1ÿ655 49ÿ326315ÿ17327 ÿ $%&&%'% 55 ÿ17327ÿ2ÿ !35456ÿ32ÿ54 9ÿ2ÿ 5 ÿ45ÿÿ325ÿ323ÿ346ÿ "57ÿ26#4ÿ7 32452ÿ2ÿ7357ÿ346ÿ32549 ()ÿ)*+ ^%T_ÿ*'V%ÿ&)* ,-./012ÿ245/1ÿ6776895.:9;ÿ ÿ53 ÿ 2#9ÿ `249ÿ3#5ÿÿ e6345ÿ5f749ÿ346ÿ 3547ÿ346ÿ75ÿ 45"ÿ2543 gf346ÿhÿ72549 54 655 54ÿÿ326315ÿ " ÿ0 #aÿ
Slide 4: 012345ÿ73ÿ892 4ÿ19 32ÿ55952 !9 32ÿ73ÿ23 "ÿ2984ÿ32#5 01234573ÿ392ÿ19 32ÿ55952 0ÿ79494ÿ9523394ÿ4ÿ295ÿÿ 235ÿ9299ÿ3 254ÿÿ…
012345ÿ73ÿ892 53 4ÿ19 32ÿ55952 !9 32ÿ73ÿ23 "ÿ2984ÿ32#5 01234573ÿ392ÿ19 32ÿ55952 0ÿ79494ÿ9523394ÿ4ÿ295ÿÿ 235ÿ9299ÿ3 254ÿÿ14ÿ4ÿ924392ÿ35ÿ
Slide 5: hijklmjnoÿqkrstuvÿÿ ÿ yz{ÿ|}~ hijklmjnoÿqkrstuvÿÿ
%6'%%9'ÿ ÿ76996+6)ÿ,6!"#'ÿ6ÿ%6968%#'ÿ9")#&!ÿ,6'ÿ,)ÿ-,%( 56789:68;< 7;;ÿ ;98:;9< 56;68< 1 234ÿ67ÿ896 9ÿ ÿÿÿ 1 .34ÿ67ÿ896 9ÿ ÿ/0ÿÿ1 1 6!"#!ÿ$%ÿ#& %#9ÿ'()&'%' 1 6!"#!ÿ$%ÿ#6 %))ÿ234ÿ#&)6968( 1 *6996+!ÿ6)ÿ(ÿ%!)%#9ÿ8)%#'ÿÿ,)ÿ-,%( 1 *6996+!ÿ6)ÿ(ÿ%6'%%9'ÿÿ,)ÿ-,%( hijklmjnoÿqkrstuvÿÿ hijklmjnoÿqkrstuvÿÿ ÿ
Slide 6: mommnÿ ÿÿ nopÿ o
1234252678ÿ 63 5 ÿ748ÿ342 ÿÿ63ÿ824 CqGwwE BJ74ÿK BJ74ÿKKK mommnÿ ÿÿ ~@ >@ nopÿ o L 63 5 ÿ25 e7276ÿ8fg285 B83¢£ÿ3ÿ4g44ÿ «oÿ¬¬mp ~ÿcSdW_ jk¡¡ÿmnnmop ¤¥¦§¨¤ÿa©§ª© oÿmpÿ L243 8MÿÿL 635 B862276ÿ CDEFGÿI BJ74ÿKK BJ74ÿKKK PQRSTÿVW
Slide 7: _8EAHÿ@A;BACAD87BÿIEG8`6ÿD68HAF9ÿG;ÿabcÿdde?@FÿAFÿ9D;@8DÿB8D6Bÿfghgdi 4567896ÿ;<ÿ=>?ÿ@A;BACAD87BÿE67ÿ;7A9AF8G;7ÿE7;HI…
12342526784ÿ8726ÿ6725ÿ57382ÿ3ÿ88ÿ83 ÿ578ÿ478 _8EAHÿ@A;BACAD87BÿIEG8`6ÿD68HAF9ÿG;ÿabcÿdde?@FÿAFÿ9D;@8DÿB8D6Bÿfghgdi KLMNOLPQRÿTLOUVWXÿYÿZOV[Rÿ\VX[N]W^X 187 ÿ834ÿ°°ÿ776ÿ4764 ±}rvqprÿ²²ÿqtqÿrq~r A;BACAD87Bÿ856ÿAFÿ76J6FGÿD8IFJ6BÿG8`6Fÿhÿ ³ÿ52623 ³ÿ52623 5;DIC6ÿC87`6GÿB876ÿm4ÿ88ÿ83 ÿ2
Slide 8: IJKLKMJNOÿQJRSÿTUVWÿ$X)YZÿJZÿO[L\OÿLKO\ÿ\]NL^OJ_JR`ÿY`ÿ$)#$ IJKOJaJL[bÿa[bc\RÿRKÿMbKQÿY`ÿd'eÿf\bÿ̀\[bÿRSbK^MSÿRKÿ$)#)ÿ
1234252678ÿ578 ÿ ÿ3ÿ83ÿ3ÿÿÿÿ IJKLKMJNOÿQJRSÿTUVWÿ$X)YZÿJZÿO[L\OÿLKO\ÿ\]NL^OJ_JR`ÿY`ÿ$)#$ IJKOJaJL[bÿa[bc\RÿRKÿMbKQÿY`ÿd'eÿf\bÿ̀\[bÿRSbK^MSÿRKÿ$)#)ÿ gORJa[R\hÿN^a^L[RJ_\ÿMLKY[Lÿ[ZZ^[Lÿf\[cÿO[L\OiÿUVWÿYJLLJKZ mLKY[LÿYJKOJaJL[bÿO[L\OiÿUVWÿYJLLJKZ '(%) ! ! #$%& ! ! ! 0 0 " 0 ! ! 0 " !0" !0" j & $ ( k l
Slide 9: 123456ÿ84ÿ9 645ÿ243ÿ66 "43ÿ84ÿ34#ÿ395ÿ43$6 12345684ÿ43ÿ243ÿ66 63 1ÿ8 55ÿ63445ÿ5ÿ36ÿÿ 346ÿ3ÿ4 365ÿÿ!25ÿ5ÿ3543ÿ46ÿ 0
123456ÿ84ÿ9 3 645ÿ243ÿ66 63 "43ÿ84ÿ34#ÿ395ÿ43$6 12345684ÿ43ÿ243ÿ66 63 1ÿ8 55ÿ63445ÿ5ÿ36ÿÿ 346ÿ3ÿ4 365ÿÿ!25ÿ5ÿ3543ÿ46ÿ 0
Slide 10: <567 E 776ÿ 7 6ÿ 8ÿ 75 ÿ44 47ÿ84 ÿ777 GSÿ'##!"2%0ÿ'.0ÿTUÿ#%.0$.3ÿ#'&%.&+
<567E 776ÿ7 6ÿ 8ÿ75ÿ4447ÿ84ÿ777 !"#!$%&'!(ÿ*"+&ÿ,%--ÿ-$.%ÿ-$/!'!( !"01,&$2$&(ÿ%.*'.,$.3ÿ&%,*."-"3$%+ !",%++ÿ'.0ÿ'.'-(&$,'-ÿ4%&*"0+ 5 5 2 3456768ÿ ÿ6 64768ÿ 478ÿ 2 867448ÿ7ÿ?7748ÿ74ÿ 2 6 44ÿ674ÿ6ÿ ÿ 4 6ÿ4 ÿ 4 7ÿ7 ÿ76ÿ77847ÿ 2 7 ÿ 7ÿ ÿ ÿ 2 7 ÿ3>@9ÿ7 9ÿAB6CABÿ 4ÿ4ÿ64ÿ 6774ÿ ?7 9ÿ= ÿ 44D74 2 7 ÿ8 6749ÿ6
Slide 11: ABCDEFEÿ HIJKJLIMN OPFBCQFRSIMÿ
1234564ÿ84349 4ÿ 592ÿ8854662ÿÿ ÿ54 ~ÿÿÿÿÿÿ '()*(+(,-.ÿ 5(+,60(7 '88'9:; 52(<-14 52-.=-14 >6..413ÿ?).3@),() 0-12(2-34 ABCDEFEÿ HIJKJLIMN OPFBCQFRSIMÿ TQPSPCKUJKJLV WUURDJKJLV TDMJKJLV TDMJKJLV CBFC XCSFDSÿFYQIBV Z[Z[ÿ\]^_ÿ Z[Zaÿ\]^_ÿ Z[Zcÿ\]^_ÿ Z[Zcÿ\]^_ÿ Z[ZZÿ\
Slide 12: N"-,OPQRSTUÿWQXYTPXZ[SWZÿZP\]XPRÿ^SY[ÿ_`abcÿSTÿ]W\dcSTUÿcSOPZYdTPZ
N"-,OPQRSTUÿWQXYTPXZ[SWZÿZP\]XPRÿ^SY[ÿ_`abcÿSTÿ]W\dcSTUÿcSOPZYdTPZ 2345678 9 67 4 37ÿ2383 !"#$"ÿ&'ÿ()*$ !"#$" + (,-."+/* 01*2 3+4* 56789 :;<ÿ oÿ5qA9ÿ r+*-*?s ="2*2ÿ>ÿ(2ÿ1.$? 5@ABC :;<ÿ D$"2>ÿ+4ÿ2)$*? EFGÿHIJKLÿ+4ÿ2)$*? D$" K."+/*ÿ2+*2#" M#$* M#$*ÿ+,1"*1$" I?*ÿ1"*1$"ÿ$*-ÿ? 2ef44ghÿi34jÿi383kÿf6lllÿ45
Slide 13: 234567ÿ95ÿ 756ÿ354ÿ77 #54ÿ95ÿ45$ÿ4 6ÿ54%7 23456795ÿ54ÿ354ÿ77 74 2ÿ9 66ÿ74556ÿ6ÿ47ÿÿ 457ÿ4ÿ5 476ÿ ÿ!"36ÿ6ÿ4654ÿ57ÿ 01
234567ÿ95ÿ 4 756ÿ354ÿ77 74 #54ÿ95ÿ45$ÿ4 6ÿ54%7 23456795ÿ54ÿ354ÿ77 74 2ÿ9 66ÿ74556ÿ6ÿ47ÿÿ 457ÿ4ÿ5 476ÿ ÿ!"36ÿ6ÿ4654ÿ57ÿ 01
Slide 14: d*I*ÿ3657ÿ5 84*ÿ655 ÿ 35ÿ7ÿe8feÿ 3fÿ497 /012,345ÿ789ÿ:;7<=>=?ÿ@=A7>=9ÿB7CDA7@ÿE=9=B7ÿ/0:FG45 *5 9ÿ7ÿ 575 8 …
ÿ!!"#ÿÿ#$%ÿ"!&ÿ'( 23456789ÿ395ÿ86ÿ757567ÿÿ9555ÿ55ÿ895959 d*I*ÿ3657ÿ584*ÿ655ÿ35ÿ7ÿe8feÿ 3fÿ497 Lÿ8**86ÿ5475 ÿ559ÿQ3R5ÿSÿTUVÿLMWÿ7575 +5475ÿ8986 )*ÿ8986 X"(( Y"(! Z[ 2&!(" MKN JKL JKL OKO MKP Oaÿ8**86ÿ5475 ÿ559ÿb597ÿÿc*VÿLWÿ7575 ^ ^] ]0 0 ,"ÿ"($"!ÿ- (ÿ#.(ÿÿ#"($"ÿ /012,345ÿ789ÿ:;7<=>=?ÿ@=A7>=9ÿB7CDA7@ÿ
Slide 15: Q0+*ÿ5+R5.-;4)ÿ30/4)55ÿ54-,)O+3 80)OP:,,)9ÿ510:;*)ÿ9)=),/3>);.
6789 7ÿ98ÿÿÿÿ7ÿ79ÿ 2322 2324 2325 ()*+,-./01ÿ30/4)55ÿ67 80/9+4.:/;ÿ,-+;4<ÿ=/,+>)? ()*+,-./01ÿ30/4)55ÿ7@ Q0+*ÿ5+R5.-;4)ÿ30/4)55ÿ54-,)O+3 80)OP:,,)9ÿ510:;*)ÿ9)=),/3>);. L-04<ÿ2324 TJQMÿ +;)ÿ2324 M30:,ÿ2325 Y2ÿ2325 SWÿ232X %ÿ &'97ÿ !9"ÿ # 7ÿ#$$ -44)3.5ÿ 6+0/3)ÿ,-+;4< UVMÿ 6N3)4.)9ÿ7@ÿ L6S2ÿ2325 7@ AMÿ,
Slide 16: s-t0uv-wx7-,-x.
23456738ÿ ÿÿÿÿÿÿ ÿ!"#ÿ4%&'() *+,-./0ÿ/.,-23456ÿ7/0+7ÿ8+9ÿ:;< s-t0uv-wx7-,-x. ÿ= y 2345673nÿz@ÿ3JÿF3HG3435%&ÿ4%&'()?Bÿ@>@A 2F&%J(ÿ y CJo!6G(&ÿLH564(ÿq&({ÿ{3)iÿ@plÿLGrÿ?Aÿ@>@A 0>>> (gh(7)%)3HJÿ)i%)ÿ F3HG3435%&GÿHL(&ÿ y |}ÿÿ}ÿ~ÿÿ}ÿÿÿ=ÿ = ÿ )34(ÿGi%55ÿ)%'(ÿ 4%&'() jk>lÿHmÿ y L(&%55ÿF3HG3435%&ÿ4%&'()ÿ
Slide 17: CDÿFGHIHÿJÿHKLMKNKOJMPÿGFFGQPRMKPSÿNGQÿTKUVROKWÿÿXYZ[ÿ\HCY[]JPIÿKMÿ[FQKVÿ^_^`
CDÿFGHIHÿJÿHKLMKNKOJMPÿGFFGQPRMKPSÿNGQÿTKUVROKWÿÿXYZ[ÿ\HCY[]JPIÿKMÿ[FQKVÿ^_^` 67+.-84ÿ8-+.9:;<=ÿ>847>ÿ?@AB '(()*+,-.+/ÿ1)*ÿ2.34,5. CDZÿUKVVKGM J]][KFPFKGQMGJzgVÿÿJCDMMZÿR0JxVÿU_Uÿ{ÿnRJQPIQÿ JQhIPÿNQGUÿGNNÿ a TKUVROK\HCY[]JPIÿNGQÿTKUVROKWKMÿ[FQKVÿ^_^` ^x__ VJiIVÿ[eJHPKM0 a bJM]NRVÿGNÿKMPIQIHPI]ÿFJQPK
Slide 18: 234567ÿ95ÿ 756ÿ354ÿ77 #54ÿ95ÿ45$ÿ4 6ÿ54%7 23456795ÿ54ÿ354ÿ77 74 2ÿ9 66ÿ74556ÿ6ÿ47ÿÿ 457ÿ4ÿ5 476ÿ ÿ!"36ÿ6ÿ4654ÿ57ÿ 01
234567ÿ95ÿ 4 756ÿ354ÿ77 74 #54ÿ95ÿ45$ÿ4 6ÿ54%7 23456795ÿ54ÿ354ÿ77 74 2ÿ9 66ÿ74556ÿ6ÿ47ÿÿ 457ÿ4ÿ5 476ÿ ÿ!"36ÿ6ÿ4654ÿ57ÿ 01
Slide 19: gh/ij/.kÿ/mÿ.ÿ+,-./01/2/345ÿ31.3ÿ5nopqnÿ/iip0nÿ 5nmr40mnÿ/0ÿ.p34s/iip0nÿo/mn.mnm g+1nÿ40tuÿ+,-./01/2/345ÿv/31ÿqt/0/q.…
ÿÿÿ!"##ÿ$%&'ÿ())*"ÿ+,-./01/2/345 2345367ÿ39ÿ6ÿ3 36 ÿ6333 ÿÿÿÿÿÿ¡¢¡ 78463ÿ9339ÿ:79; 6936939 2345367ÿÿÿ 0 0 gh/ij/.kÿ/mÿ.ÿ+,-./01/2/345ÿ31.3ÿ5nopqnÿ/iip0nÿ 5nmr40mnÿ/0ÿ.p34s/iip0nÿo/mn.mnm 0 0 01 0 g+1nÿ40tuÿ+,-./01/2/345ÿv/31ÿqt/
Slide 20: I 8A> 8HJ=7ÿK=AJÿ2=9 >ÿK=AJÿ AA8 EA=@ ÿA 8 H
1 ÿÿÿ!ÿ"#$%&ÿ'#%(ÿ)(ÿ)*# 2332456 7898 I8A>8HJ=7ÿK=AJÿ2=9 >ÿK=AJÿAA8EA=@ÿA8 H + ,ÿ'%ÿ(''ÿ'%')ÿ + -/'.ÿ0ÿ.%ÿ(.' + -..ÿ/(%'0(1'%/ÿÿ')ÿ)(.ÿ + 3(%ÿ(''ÿ0(ÿ%)ÿ0)ÿ(/%ÿ ''%ÿ#%0%(( )*# + 2%(..ÿ%(*%ÿ0ÿ%ÿ)%'ÿ0ÿ(0(ÿ() + .ÿ(''ÿ0(ÿ%)ÿ0)ÿ%ÿ%)ÿ(.%(ÿ )*#ÿ%'ÿ!ÿ%'ÿ##(%$%ÿ.% + 2%(.)ÿ%(*%ÿ%)ÿ%ÿ%(''ÿ#'ÿ((('ÿ + 456ÿÿ#ÿ/0(7
Slide 21: U2//E1785457,2AÿVÿ67BB2365.//Kÿ.443.645F2ÿ7,67/7DKÿH5785B5/.3ÿ173497/57
U2//E1785457,2AÿVÿ67BB2365.//Kÿ.443.645F2ÿ7,67/7DKÿH5785B5/.3ÿ173497/57 2334567896ÿ64ÿ ÿÿ958 284P4tÿX94Y99P5ÿ34564P94 abcÿefggfhiÿhjÿkiilkgÿmnjnmnionÿpmhqlorÿskgns W4 X98ÿ887PÿQ36ÿ3ÿ * +,,-./ÿ123ÿ1.452,4ÿ6784ÿ79ÿ 259t98 645 558ÿ35476ÿYPY :;<=ÿ1>>? Zÿ\]^^]_` 9L8 u4v wwxxwwy~ÿÿzz{|} 0> * @3-65./ÿ137A
Slide 22: 12345678ÿ ÿ5647 ÿ00ÿ65364637678ÿ4ÿ4ÿ5 637ÿ68 ÿ00ÿ6536 !ÿ224"ÿ ÿ00ÿ#6"7$% 4637678 &'ÿ00ÿ())(*ÿ5647ÿ25 7ÿ3476787ÿ247ÿ33…
12345678ÿ ÿ5647 ÿ00ÿ65364637678ÿ4ÿ4ÿ5 637ÿ68 ÿ00ÿ6536 !ÿ224"ÿ ÿ00ÿ#6"7$% 4637678 &'ÿ00ÿ())(*ÿ5647ÿ25 7ÿ3476787ÿ247ÿ33ÿ3 2 0ÿ00ÿ6536ÿ1+ÿ73 &ÿ00,ÿ-3678ÿ2466"ÿ42678ÿ34.ÿ47ÿÿ547 ÿ/6 00
Slide 23: 234567ÿ95ÿ 756ÿ354ÿ77 74ÿ
234567ÿ95ÿ 4 756ÿ354ÿ77 74ÿ 01
Slide 24: abcdefdghdiÿklglmdkdgnÿndlkÿlgiÿoplei
abcdefdghdiÿklglmdkdgnÿndlkÿlgiÿoplei PQRQSTUTRV WXQYZÿX\ÿ]^YT_VXY` &6%3ÿ=+63 77'87'6 14ÿ237%64+ 234567ÿ$ 7%64+ 234567ÿ9 653 ÿ7 64 #63ÿ$3 7%634 &%7ÿ9'(6)3 >6 66ÿ9ÿ:ÿÿ 56 :ÿÿ?@"@Aÿ ÿÿÿ !"ÿÿÿ !"ÿÿÿ !"ÿÿÿ ;<; ÿB@CC<Dÿ 235%%5ÿE34F7% 13ÿJ 6+3 &6ÿ45L633 M(N 3ÿ.567 *5%56ÿ4+3 #67%ÿ,-5 3 .3ÿ/('53093 G6ÿ9ÿ:ÿÿ
Slide 25: =" : "9($ :ÿ('!)ÿh % <i :ÿ7879j C.5D+1ÿE7FG+ J-1K,ÿLM6+1ÿN-.,O+1
*+,-.,ÿ/01+120+3.ÿ4ÿ.5+6-5738-6ÿ30., =":"9($:ÿ('!)ÿh %<i:ÿ7879j k' %'(ÿ"'`"('`")! !)9:ÿ; < =":! >? :!"'@AÿB C.5D+1ÿE7FG+ 0H0 HI 234ÿ6 7879 7877 J-1K,ÿLM6+1ÿN-.,O+1 0 I0 PQCRCÿC6S1-0O0,,-3ÿCL 1H 1I0 0 1 CT+1S+ÿE-1.071 100 IH UVD+1ÿP,M8W-6K I PX-8W+1DÿY7WF6ÿZ718-6 H0 IH ÿ0 ÿ [7681-,ÿE-1.071./M6.\D601K
Slide 26: / 6478ÿÿ076ÿ1 2345674889ÿ 5ÿ576ÿ7ÿÿ45ÿÿÿ7887ÿ76ÿ45546ÿ467ÿÿ6ÿ4ÿ476748ÿ45ÿ ÿÿ7887!ÿ4ÿ45"ÿ46ÿ6ÿ#$ÿ8ÿ00ÿ%&5459 2'5ÿÿ0(ÿ7…
/ 6478ÿÿ076ÿ1 2345674889ÿ 5ÿ576ÿ7ÿÿ45ÿÿÿ7887ÿ76ÿ45546ÿ467ÿÿ6ÿ4ÿ476748ÿ45ÿ ÿÿ7887!ÿ4ÿ45"ÿ46ÿ6ÿ#$ÿ8ÿ00ÿ%&5459 2'5ÿÿ0(ÿ7887ÿ 5ÿ65ÿ4ÿ&7467ÿÿ& 5767ÿ564)7ÿ4ÿ7667ÿÿ 45ÿÿ(1ÿ7887ÿ4ÿ4546 ÿ564)7ÿÿ45ÿÿ00*ÿ7887 2+ÿ45ÿ7" ÿ6ÿ576ÿ6ÿ& 57&ÿ5ÿÿ76ÿ7ÿ76ÿÿ(,ÿÿ45 ÿ4ÿ*ÿ45546ÿ 2-ÿ& 5767ÿ57 ÿ5ÿ76ÿ7ÿÿ..(ÿ7ÿ55 ÿ6ÿÿ,0ÿ5ÿ45!ÿ4ÿ6
Slide 27: ! 48ÿ:;<ÿ=<:ÿ>?@A<<BCÿD?@Eÿ:;<ÿFGH;:CÿICCJ<ÿK?<ÿ<L><A:<Bÿ:@ÿDJMDGMMÿ:;<ÿN@E>K=OPCÿQ@?RG=HÿAK>G:KMÿ?<SJG?<E<=:ÿJ=:…
234ÿ67ÿ896443 4ÿ4ÿ96443ÿ796ÿ4ÿ3ÿ334ÿ964ÿÿ4ÿ3ÿ334ÿ3ÿ3394ÿ6ÿ4ÿ6ÿ44ÿ6ÿ4ÿ6494ÿÿ 3396ÿ643ÿÿ463ÿ3ÿ4ÿ3ÿ944ÿ643ÿÿ99ÿ74 ÿ67ÿ!"ÿÿ2#ÿÿÿ67ÿ!8$#ÿ%96&'ÿ()ÿ494*+ 8966ÿ67ÿÿ49ÿ769ÿ,,-).ÿ949ÿ4364ÿ43ÿ796ÿ649/6ÿ949ÿ,64ÿ %96&'ÿ.)ÿ494*+ 04464ÿÿ966ÿ67ÿÿ49ÿ769ÿ!4 %96&'ÿ.1ÿ494*+ 2449ÿ69694ÿ96343ÿ%96&'ÿ1ÿ494*+ÿ 89434ÿ67ÿ4ÿ4&
Slide 28: 234567896ÿ34ÿ6878794 88494ÿ68ÿÿ0ÿ9934ÿ4394ÿ348 ÿ3789!8934ÿ3ÿÿ"#ÿ9934ÿ73ÿ468$7366ÿ73ÿ44346ÿ79%8ÿ96 69494ÿ388494ÿ68ÿ3ÿÿ…
234567896ÿ34ÿ6878794 88494ÿ68ÿÿ0ÿ9934ÿ4394ÿ348 463 ÿ3789!8934ÿ3ÿÿ"#ÿ9934ÿ73ÿ468$7366ÿ73ÿ44346ÿ79%8ÿ96 69494ÿ388494ÿ68ÿ3ÿÿ&"ÿ9934ÿ 66ÿ9348%'ÿ3789!8934ÿ73ÿ(47'ÿ0)0&ÿ34*7 +78934ÿ489ÿ,'ÿ0)0- 234567934ÿ$796ÿÿ# .486768ÿ786ÿ3ÿ"/ÿ489ÿ0+1ÿ$$7352ÿ8%676867ÿ)/ 01

Xbrane Biopharma — Investor Presentation (March 2024) on 6ix